Additionally, some NNMT inhibitors (NNMTi) have been used to treat and/or prevent obesity and obesity-driven comorbidities in both preclinical animal models and 3T3-L1 cell line25,26. The gene discussed is NNMT; the disease is obesity due to melanocortin 4 receptor deficiency.